全文获取类型
收费全文 | 1424篇 |
免费 | 118篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 49篇 |
妇产科学 | 15篇 |
基础医学 | 235篇 |
口腔科学 | 5篇 |
临床医学 | 138篇 |
内科学 | 334篇 |
皮肤病学 | 65篇 |
神经病学 | 102篇 |
特种医学 | 58篇 |
外科学 | 151篇 |
综合类 | 17篇 |
一般理论 | 1篇 |
预防医学 | 139篇 |
眼科学 | 13篇 |
药学 | 127篇 |
中国医学 | 1篇 |
肿瘤学 | 79篇 |
出版年
2022年 | 10篇 |
2021年 | 27篇 |
2020年 | 22篇 |
2019年 | 37篇 |
2018年 | 39篇 |
2017年 | 27篇 |
2016年 | 27篇 |
2015年 | 34篇 |
2014年 | 40篇 |
2013年 | 56篇 |
2012年 | 65篇 |
2011年 | 73篇 |
2010年 | 39篇 |
2009年 | 57篇 |
2008年 | 66篇 |
2007年 | 61篇 |
2006年 | 56篇 |
2005年 | 82篇 |
2004年 | 56篇 |
2003年 | 47篇 |
2002年 | 50篇 |
2001年 | 44篇 |
2000年 | 39篇 |
1999年 | 42篇 |
1998年 | 12篇 |
1997年 | 11篇 |
1996年 | 10篇 |
1995年 | 10篇 |
1994年 | 8篇 |
1993年 | 10篇 |
1992年 | 29篇 |
1991年 | 29篇 |
1990年 | 21篇 |
1989年 | 32篇 |
1988年 | 25篇 |
1987年 | 21篇 |
1986年 | 23篇 |
1985年 | 14篇 |
1984年 | 18篇 |
1983年 | 15篇 |
1982年 | 17篇 |
1980年 | 11篇 |
1979年 | 12篇 |
1978年 | 13篇 |
1975年 | 9篇 |
1974年 | 14篇 |
1970年 | 8篇 |
1969年 | 7篇 |
1968年 | 8篇 |
1966年 | 8篇 |
排序方式: 共有1546条查询结果,搜索用时 15 毫秒
1.
Paula C. Salamone Agustina Legaz Lucas Sedeo Sebastin Moguilner Matías Fraile-Vazquez Cecilia Gonzalez Campo Sol Fittipaldi Adrin Yoris Magdalena Miranda Agustina Birba Agostina Galiani Sofía Abrevaya Alejandra Neely Miguel Martorell Caro Florencia Alifano Roque Villagra Florencia Anunziata Maira Okada de Oliveira Ricardo M. Pautassi Andrea Slachevsky Cecilia Serrano Adolfo M. García Agustín Ibaez 《The Journal of neuroscience》2021,41(19):4276
Recent frameworks in cognitive neuroscience and behavioral neurology underscore interoceptive priors as core modulators of negative emotions. However, the field lacks experimental designs manipulating the priming of emotions via interoception and exploring their multimodal signatures in neurodegenerative models. Here, we designed a novel task that involves interoceptive and control-exteroceptive priming conditions followed by post-interoception and post-exteroception facial emotion recognition (FER). We recruited 114 participants, including healthy controls (HCs) as well as patients with behavioral variant frontotemporal dementia (bvFTD), Parkinson''s disease (PD), and Alzheimer''s disease (AD). We measured online EEG modulations of the heart-evoked potential (HEP), and associations with both brain structural and resting-state functional connectivity patterns. Behaviorally, post-interoception negative FER was enhanced in HCs but selectively disrupted in bvFTD and PD, with AD presenting generalized disruptions across emotion types. Only bvFTD presented impaired interoceptive accuracy. Increased HEP modulations during post-interoception negative FER was observed in HCs and AD, but not in bvFTD or PD patients. Across all groups, post-interoception negative FER correlated with the volume of the insula and the ACC. Also, negative FER was associated with functional connectivity along the (a) salience network in the post-interoception condition, and along the (b) executive network in the post-exteroception condition. These patterns were selectively disrupted in bvFTD (a) and PD (b), respectively. Our approach underscores the multidimensional impact of interoception on emotion, while revealing a specific pathophysiological marker of bvFTD. These findings inform a promising theoretical and clinical agenda in the fields of nteroception, emotion, allostasis, and neurodegeneration.SIGNIFICANCE STATEMENT We examined whether and how emotions are primed by interoceptive states combining multimodal measures in healthy controls and neurodegenerative models. In controls, negative emotion recognition and ongoing HEP modulations were increased after interoception. These patterns were selectively disrupted in patients with atrophy across key interoceptive-emotional regions (e.g., the insula and the cingulate in frontotemporal dementia, frontostriatal networks in Parkinson''s disease), whereas persons with Alzheimer''s disease presented generalized emotional processing abnormalities with preserved interoceptive mechanisms. The integration of both domains was associated with the volume and connectivity (salience network) of canonical interoceptive-emotional hubs, critically involving the insula and the anterior cingulate. Our study reveals multimodal markers of interoceptive-emotional priming, laying the groundwork for new agendas in cognitive neuroscience and behavioral neurology. 相似文献
2.
Rosa Della Monica Mariella Cuomo Roberta Visconti Annabella di Mauro Michela Buonaiuto Davide Costabile Giulia De Riso Teodolinda Di Risi Elia Guadagno Roberto Tafuto Sabrina Lamia Alessandro Ottaiano Paolo Cappabianca Maria Laura Del Basso de Caro Fabiana Tatangelo Juergen Hench Stephan Frank Salvatore Tafuto Lorenzo Chiariotti 《Oncology research》2020,28(9):837-845
Unresectable neuroendocrine neoplasms (NENs) often poorly respond to standard therapeutic approaches.
Alkylating agents, in particular temozolomide, commonly used to treat high-grade brain tumors including glioblastomas, have recently been tested in advanced or metastatic NENs, where they showed promising response
rates. In glioblastomas, prediction of response to temozolomide is based on the assessment of the methylation
status of the MGMT gene, as its product, O6
-methylguanine-DNA methyltransferase, may counteract the damaging effects of the alkylating agent. However, in NENs, such a biomarker has not been validated yet. Thus, we
have investigated MGMT methylation in 42 NENs of different grades and from various sites of origin by two
different approaches: in contrast to methylation-specific PCR (MSP), which is commonly used in glioblastoma
management, amplicon bisulfite sequencing (ABS) is based on high-resolution, next-generation sequencing
and interrogates several additional CpG sites compared to those covered by MSP. Overall, we found MGMT
methylation in 74% (31/42) of the NENs investigated. A higher methylation degree was observed in welldifferentiated tumors and in tumors originating in the gastrointestinal tract. Comparing MSP and ABS results,
we demonstrate that the region analyzed by the MSP test is sufficiently informative of the MGMT methylation
status in NENs, suggesting that this predictive parameter could routinely be interrogated also in NENs. 相似文献
3.
4.
Jara Ampuero Mencía Almudena Vega Soraya Abad Caridad Ruiz Caro Úrsula Verdalles Juan Manuel López Gómez 《Nefrología : publicación oficial de la Sociedad Espa?ola Nefrologia》2019,39(1):44-49
Background
Hypertension is a highly prevalent disorder among patients undergoing haemodialysis. It contributes to greater cardiovascular risk and must be controlled. However, despite dietary measures, haemodialysis regimen optimisation and pharmacological treatment, some patients in our units continue to maintain high blood pressure levels. The objective of the study is to demonstrate that reducing calcium in dialysis fluid can help treat hypertension patients undergoing haemodialysis.Material and methods
We selected all of the hypertensive patients from our haemodialysis unit. We checked their normovolemic status by means of bioimpedance spectroscopy, decreasing the haemodialysis fluid's calcium concentration to 2.5 mEq/l, with a follow-up period of 12 months.Results
A total of 24 patients met the non-volume dependent hypertension criteria (age 61 ± 15 years, males 48%, diabetes 43%). A significant systolic and diastolic blood pressure decrease was observed at 6 and 12 months as a result of reducing the dialysis calcium concentration; this was not accompanied by greater haemodynamic instability (baseline systolic blood pressure: 162 ± 14 mmHg; at 6 months: 146 ± 18 mmHg; at 12 months: 141 ± 21 mmHg; P = .001) (baseline diastolic blood pressure: 76 ± 14 mmHg; at 6 months: 70 ± 12 mmHg; at 12 months: 65 ± 11 mmHg; P = .005). A non-significant increase in plasma parathyroid hormone levels was also found. No side effects were observed.Conclusions
Adding 2.5 mEq/l of calcium to dialysis fluid is a safe and effective therapeutic alternative to control hard-to-manage hypertension among haemodialysis patients. 相似文献5.
6.
Moncada GC Martin J Fernandez E Vildosola PG Caamano C Caro MJ Mjor IA Gordan VV 《General dentistry》2006,54(5):314-318
This clinical trial sought to evaluate the effectiveness of alternative treatment for replacing amalgam and resin-based composite restorations with marginal defects. The study recruited 66 patients with 271 restorations. Each restoration was assigned randomly to one of five groups: Sealant, Refurbishing, Repair, Replacement, and Untreated. Two clinicians evaluated the restorations according to USPHS/Ryge criteria at baseline (Kappa 0.74) and one year after the treatment (Kappa 0.81). The scoring of the margins improved (from bravo to alfa) after the experimental treatments. None of the treatments showed significant degradation of the margins during the 12-month observation period. 相似文献
7.
Unique association of hypochondroplasia with craniosynostosis and cleft palate in a Mexican family 下载免费PDF全文
8.
Veronika E. Neubrand Irene Forte-Lago Marta Caro Mario Delgado 《Journal of neuroinflammation》2018,15(1):343
Background
Over-activated microglia play a central role during neuroinflammation, leading to neuronal cell death and neurodegeneration. Reversion of over-activated to neuroprotective microglia phenotype could regenerate a healthy CNS-supporting microglia environment. Our aim was to identify a dataset of intracellular molecules in primary microglia that play a role in the transition of microglia to a ramified, neuroprotective phenotype.Methods
We exploited the anti-inflammatory and neuroprotective properties of conditioned medium of adipose-derived mesenchymal stem cells (CM) as a tool to generate the neuroprotective phenotype of microglia in vitro, and we set up a microscopy-based siRNA screen to identify its hits by cell morphology.Results
We initially assayed an array of 157 siRNAs against genes that codify proteins and factors of cytoskeleton and activation/inflammatory pathways in microglia. From them, 45 siRNAs significantly inhibited the CM-induced transition from a neurotoxic to a neuroprotective phenotype of microglia, and 50 siRNAs had the opposite effect. As a proof-of-concept, ten of these targets were validated with individual siRNAs and by downregulation of protein expression. This validation step resulted essential, because three of the potential targets were false positives. The seven validated targets were assayed in a functional screen that revealed that the atypical RhoGTPase RhoE/Rnd3 is necessary for BDNF expression and plays an essential role in controlling microglial migration.Conclusions
Besides the identification of RhoE/Rnd3 as a novel inducer of a potential neuroprotective phenotype in microglia, we propose a list of potential targets to be further confirmed with selective activators or inhibitors.9.
Noelia Vicente Oliveros PharmD Covadonga Pérez Menendez‐Conde PharmD PhD Teresa Gramage Caro PharmD Ana María Álvarez Díaz PharmD Manuel Vélez‐Díaz‐Pallarés PharmD PhD Beatriz Montero Errasquín MD Gema Nieto Gómez RN Teresa Rodríguez Cubilot RN Sagrario Martín‐Aragón Álvarez PhD Teresa Bermejo Vicedo PharmD PhD Eva Delgado Silveira PharmD PhD 《Journal of evaluation in clinical practice》2016,22(5):745-750
10.
D A Schoeller L K Cella M K Sinha J F Caro 《The Journal of clinical investigation》1997,100(7):1882-1887
To identify the physiologic factor(s) that entrain the diurnal rhythm of plasma leptin, leptin levels were measured hourly after changes in light/dark cycle, sleep/wake cycle, and meal timing. Four young male subjects were studied during each of two protocols, those being a simulated 12-h time zone shift and a 6.5-h meal shift. During the baseline day, plasma leptin demonstrated a strong diurnal rhythm with an amplitude of 21%, zenith at 2400 h, and nadir between 0900 and 1200 h. Acute sleep deprivation did not alter plasma leptin, but day/night reversal (time zone shift) caused a 12+/-2 h shift (P < 0.01) in the timing of the zenith and nadir. When meals were shifted 6.5 h without changing the light or sleep cycles, the plasma leptin rhythm was shifted by 5-7 h (P < 0.01). The phase change occurred rapidly when compared with changes in the diurnal rhythm of cortisol, suggesting that leptin levels are not acutely entrained to the circadian clock. The leptin rhythm was altered by meal timing in a manner very similar to the rhythm of de novo cholesterol synthesis. We conclude that the diurnal rhythm of plasma leptin in young males is entrained to meal timing. 相似文献